Trials / Conditions / ER-negative Breast Cancer
ER-negative Breast Cancer
4 registered clinical trials studyying ER-negative Breast Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs NCT06176261 | Sarah Sammons, MD | Phase 2 |
| Terminated | De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo NCT04675827 | Jules Bordet Institute | Phase 2 |
| Terminated | A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002) NCT04504916 | VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 2 |
| Recruiting | Sacituzumab Govitecan In TNBC NCT04230109 | Massachusetts General Hospital | Phase 2 |